MED23 and type 2 diabetes mellitus: Third, among the 39 novel loci, there was only 1 locus (ARG1/MED23, Supplementary Fig. 17) at which the association between gene expression and T2D risk was significant in SMR and not rejected by HEIDI (Tables 2–3).